type-2

Documents about type-2

• Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients#181732ClinicalTrials.gov
• Comparison of Progressive Muscle Relaxation and Stretching Exercises in Diabetic Population#184765ClinicalTrials.gov
• Effect of an Extract of Green Tea on Adults With Type 2 Diabetes#184776ClinicalTrials.gov
• A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal#158071ClinicalTrials.gov
• The evaluation of cognitive-behavioral therapy-based intervention on type 2 diabetes patients with comorbid metabolic syndrome: a randomized controlled trial#167783Griffith Research Online
• Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease#146421ClinicalTrials.gov
• A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese#160317ClinicalTrials.gov
• Effectiveness of Dapagliflozin for Weight Loss#18536ClinicalTrials.gov
• High Protein Breakfast on Appetite, Postprandial Glycemia and Weight Loss in T2D#18795ClinicalTrials.gov
• Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes#28510ClinicalTrials.gov
• Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)#123401ClinicalTrials.gov
• Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals#123671ClinicalTrials.gov
• Bioenergetics and Metabolism in Pediatric Populations#126096ClinicalTrials.gov
• Curcumin Supplement in Nonalcoholic Fatty Liver Patients#127760ClinicalTrials.gov
• Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting#127794ClinicalTrials.gov
• The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients#140947ClinicalTrials.gov
• Screening, Brief Intervention, and Referral to Treatment in Primary Care#141194ClinicalTrials.gov
• Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital#141199ClinicalTrials.gov
• Molecular Mechanisms and Carotid Atherosclerosis#143778ClinicalTrials.gov
• Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque#143788ClinicalTrials.gov
• Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects#146357ClinicalTrials.gov
• The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication Adherence#146361ClinicalTrials.gov
• Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents#146424ClinicalTrials.gov
• Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin#158168ClinicalTrials.gov
• Dementia Risk in Type 1 and 2 Diabetes: A Nationwide Population-Based Comparison.#159726NCBI PubMed Central
• Detecting chromatin state alterations in PBMCs associated with Type 2 Diabetes Mellitus.#159901NCBI PubMed Central
• Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes#160285ClinicalTrials.gov
• Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina#162400ClinicalTrials.gov
• BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes#162414ClinicalTrials.gov
• CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)#162418ClinicalTrials.gov
• Community Health Worker-Led Postpartum Diabetes Screening#172485ClinicalTrials.gov
• Glycemic Response to Six Meal Replacements in Persons With Type 2 Diabetes Mellitus#172503ClinicalTrials.gov
• Comparative evaluation of oxidative stress biomarkers F2-isoprostanes and 8-OHdG in Parkinson's disease and Type 2 Diabetes Mellitus: a systematic review and meta-analysis of human studies.#121227PubMed
• Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes#158174ClinicalTrials.gov
• A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)#127815ClinicalTrials.gov
• Real-world predictors of progression to type 2 diabetes among adults with prediabetes.#9093NCBI PubMed Central
• Detection of Type 2 Diabetes from 20-second Speech Recordings: A Large-Scale Validation Study#12988bioRxiv / medRxiv
• Latest advances and controversies of exercise therapy in the management of type 2 diabetes.#15097NCBI PubMed Central
• Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results#18777ClinicalTrials.gov
• Palmatine ameliorates MASLD in type 2 diabetes by modulating hepatic apoptosis and inflammation.#25634NCBI PubMed Central
• Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy#28546ClinicalTrials.gov
• Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM#28594ClinicalTrials.gov
• Dietary Reduction of AGEs to Prevent Cognitive Decline in Elderly Diabetics#67782ClinicalTrials.gov
• Metformin dosage and renal protection in type 2 diabetes mellitus: Impact on estimated glomerular filtration rate#81790PhilArchive
• A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas#121269ClinicalTrials.gov
• A Cohort Study on Obese Patients' Multidisciplinary Integrated Health Management#123394ClinicalTrials.gov
• Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support#126054ClinicalTrials.gov
• Thyroid Dysfunction in Patients With Type 2 Diabetes With Early Diabetic Nephropathy.#127778ClinicalTrials.gov
• Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On Metformin#127805ClinicalTrials.gov
• Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.#127806ClinicalTrials.gov